1. Henderson IC, Hayes DF, Gelman R: Dose-response in the treatment of breast cancer: a critical review. J Clin Oncol 6: 1501–1515, 1988
2. Peters WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO: High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 6: 1368–1376, 1988
3. Jones RB, Shpall EJ, Ross M, Bast R, Affronti M, Peters WP: AFM induction chemotherapy, followed by intensive alkylating agent consolidation with autologous bone marrow support for advanced breast cancer: current results. Proc ASCO 9: 9, 1990 (Abstract)
4. Antman K, Eder J, Elias A, Ayash L, Wheeler C, Schnipper L, Frei E III: High dose cyclophosphamide, thiotepa and carboplatin intensification with autologous bone marrow support in patients with breast cancer responding to standard dose induction therapy. Proc ASCO 9: 10, 1990 (Abstract)
5. Dunphy F, Spitzer G, Buzdar A, Hortobagyi G, Horwitz L, Yau J, Spinolo J, Jagannath S, Dicke K: High-dose therapy with ABMT in metastatic breast cancer: clinical features of prolonged progression-free survival. Proc ASCO 8: 25, 1989 (Abstract)